Health
Moderna's Flu Vaccine Approved
The U.S. has approved Moderna’s mRNA flu vaccine, mFlusiva, which showed a 27 percent higher effectiveness rate in clinical trials compared to traditional vaccines.
Coverage timeline — 1 article
Scientific American
The flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab
2026-08-06 13:00 UTC